TABULA RASA HEALTHCARE ($NASDAQ:TRHC) announced their financial results for the second quarter of their fiscal year 2023 on June 30, 2023. Total revenue had increased by 24.0% compared to the same quarter in the previous year, amounting to USD 90.0 million. However, net income had decreased to -9.8 million for Q2 of FY2023, compared to -49.6 million reported in the same quarter of the prior year.
GoodWhale has conducted an analysis of TABULA RASA HEALTHCARE’s wellbeing and based on their Star Chart, the company has been given an intermediate health score of 5/10. This suggests that the company might be able to safely ride out any crisis without the risk of bankruptcy. Specifically, the company’s strengths are medium in growth, and its weaknesses are in asset, dividend, and profitability. TABULA RASA HEALTHCARE has been classified as a ‘sloth’, which indicates that the company has achieved revenue or earnings growth slower than the overall economy. This type of company may be of interest to value investors who are looking for a low-risk investment with the potential for capital appreciation. It may also be a good choice for investors who are looking for a long-term investment strategy as TABULA RASA HEALTHCARE could have potential for future growth. More…
Risk Rating Analysis
Star Chart Analysis
About the Company
Ownership (Institutional/ Fund Holdings)
Below shows the total revenue, net income and net margin for TRHC. More…
Income Statement Reports (Yearly/ Quarterly/ LTM)
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for TRHC. More…
Cash Flow Statement (Yearly/ Quarterly/ LTM)
Cash Flow Supplement
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for TRHC. More…
Balance Sheet (Yearly/ Quarterly)
Balance Sheet Supplement
||Book Value Per Share
Key Ratios Snapshot
Some of the financial key ratios for TRHC are shown below. More…
Income Statement Ratios
Balance Sheet Ratios
Cash Flow Ratios
Other Supplementary Items
|3Y Rev Growth
||3Y Operating Profit Growth
– Comprehensive Healthcare Systems Inc ($TSXV:CHS)
Comprehensive Healthcare Systems Inc is a provider of healthcare services, technologies, and products. It is a publicly traded company listed on the NASDAQ. The current market capitalization of Comprehensive Healthcare Systems Inc is 12.4 million as of 2023. The company’s return on equity is an impressive 328.25%, indicating that it has been able to generate a healthy profit from its investments. This impressive ROE indicates that Comprehensive Healthcare Systems Inc is a financially sound company with a bright future.
Smith Inc is a mobile technology platform provider. The company provides mobile application development, deployment, and management solutions for enterprises, healthcare, and financial services. Its platform helps organizations rapidly build, manage, and deploy mobile apps across multiple device platforms. As of 2023, Smith Inc has a market cap of 8.52k. Additionally, the company’s Return on Equity (ROE) is 103.39%, indicating that the company is efficiently using its resources to produce a significant amount of profit.
Carepay Inc is a payment and technology solutions provider for small- to medium-sized businesses. The company has a market cap of 109.37k as of 2023, which is considered to be relatively small compared to other large tech companies. Carepay Inc also has a Return on Equity of 18.06%, which suggests that the company is able to efficiently generate profits from its investments and that shareholders are benefitting from their ownership.
Tabula Rasa Healthcare (TRHC) reported second quarter FY2023 earnings results on June 30th 2023, with total revenue of USD 90 million, a 24.0% increase YoY. Net income for the quarter was USD -9.8 million, representing a significant improvement from last year’s -USD 49.6 million. The stock price moved up the same day, potentially in response to the quarterly earnings beat. TRHC is a viable investing option for investors looking for growth opportunities in the healthcare sector.
Its sharp YoY revenue growth and improved Q2 performance bode well for its future financials. Investors should keep an eye on TRHC’s financials going forward, as its long-term prospects are promising.